Efficacy and safety of an innovative short-course regimen containing clofazimine for treatment of drug-susceptible tuberculosis: a clinical trial
Related Posts
Wu JT, Langford BJ, Shenoy ES, Carey E, Branch-Elliman W. Chatting new territory: large language models for infection surveillance from pilot to deployment. Infect Control[...]
Zhou T, Solis NV, Marshall M, Yao Q, Pearlman E, Filler SG, Liu H. Fungal Als proteins hijack host death effector domains to promote inflammasome[...]
Wang AG, Son M, Gorin A, Kenna E, Padhi A, Keisham B, Schauer A, Hoffmann A, Tay S. Macrophage memory emerges from coordinated transcription factor[...]